Medical News

RSS

Akebia completes enrollment in ongoing 200-patient Phase 2b study of AKB-6548

Akebia Therapeutics, Inc., a biopharmaceutical company focused on the development of novel proprietary therapeutics based on hypoxia-inducible factor (HIF) biology and the commercialization of these products for patients with kidney disease, today announced it has completed enrollment in its ongoing 200-patient Phase 2b study of AKB-6548 for the treatment of anemia associated with chronic kidney disease (CKD) in patients who are not dependent on dialysis.

16 Apr 2014

Researchers evaluate rice consumption against overall diet quality and key nutrient intakes

New research, partially funded by the U.S. Department of Agriculture and the USA Rice Federation, shows that consumers can improve their diets simply by enjoying white or brown rice as part of their daily meals.

16 Apr 2014

FDA approves GSK's Tanzeum as once-weekly treatment for type 2 diabetes

GlaxoSmithKline plc today announced that the US Food and Drug Administration has approved Tanzeum (albiglutide) for injection, for subcutaneous use, as a once-weekly treatment for type 2 diabetes. Tanzeum has been approved as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

16 Apr 2014

Anika Therapeutics reports first commercial sale of Monovisc in the U.S.

Anika Therapeutics, Inc., a leader in products for tissue protection, healing and repair, based on hyaluronic acid ("HA") technology, today announced the first U.S. commercial sale of Monovisc by its commercial partner, DePuy Synthes Mitek Sports Medicine, a leading orthopedic sports medicine company.

16 Apr 2014

U.S. health care spending, usage rise

Americans' spending on medicines in 2013 rose 3.2 percent to nearly $330 billion, fueling speculation that a dip in overall health care spending may be over.

16 Apr 2014

Measurement of calcium in coronary arteries can predict heart disease risk

With growing evidence that a measurement of the buildup of calcium in coronary arteries can predict heart disease risk, Los Angeles Biomedical Research Institute (LA BioMed) researchers found that the process of "calcium scoring" was also accurate in predicting the chances of dying of heart disease among adults with little or no known risk of heart disease.

16 Apr 2014

FDA approves Boston Scientific's latest generation of defibrillators and heart failure devices

Boston Scientific Corporation has received FDA approval for its latest generation of defibrillators and heart failure devices designed to advance patient care. The newly approved devices include the DYNAGEN MINI and INOGEN MINI ICDs, as well as the DYNAGEN X4 and INOGEN X4 CRT-Ds.

16 Apr 2014

Top high school students build world's largest wiki on melanoma research

In a groundbreaking effort, 3,500 of the country's top high school students will build the world's largest wiki on melanoma research — and work toward finding that needle in a haystack to cure melanoma.

16 Apr 2014

ulrich medical USA announces release of tezo spine implants in the U.S. market

ulrich medical USA, Inc., today announced the U.S. market release of the tezo spine implants for multiple surgical approaches to lumbosacral interbody fusion.

16 Apr 2014

Disparity in Medicare provider payments in Oregon, data show

Information gleaned from the federal government's Medicare data dump shows that Oregon providers and provider groups were paid $508 million in 2012. However, some providers made more than others. Meanwhile the Milwaukee Journal Sentinel is reporting that arising from the data, Wisconsin Congressional members want physicians rated on quality of care.

16 Apr 2014

Detroit reaches agreement on pension and healthcare benefits with RDPFFA

The City of Detroit, working through federal bankruptcy mediators, has reached an agreement on pension and healthcare benefits with an association representing retired Detroit police and fire fighters – the first agreement with a major group of city retirees.

16 Apr 2014

Antibiotics improve growth in kids at risk of undernourishment in low income countries

Antibiotics improve growth in children at risk of undernourishment in low and middle income countries, according to researchers at McGill University who have just conducted a research literature review on the subject.

16 Apr 2014

Survey: Signing up for Obamacare no walk in the park

California enrollees said they had trouble getting through to call centers, calculating their income and gathering the required documentation, among other difficulties, according to a survey by the California HealthCare Foundation. Meanwhile, media outlets note that Tuesday is the last chance to sign up in California, while April 22 is the deadline in Minnesota.

16 Apr 2014

Bioniche Life Sciences sells Animal Health business to Vétoquinol

Vétoquinol and Bioniche Life Sciences Inc., today jointly announced the closing of the sale of Bioniche's Animal Health business to Vétoquinol.

16 Apr 2014

Researchers develop screening tool to identify infants prior to 12 months at risk for ASD

The aim of this study was to develop a screening tool to identify infants prior to 12 months at risk for autism spectrum disorder (ASD) and developmental learning delay (DLD) and provide immediate determination of risk for autism spectrum disorder.

16 Apr 2014

Eating Recovery Center collaborates with Eating Disorder Center at San Antonio

Eating Recovery Center (www.EatingRecoveryCenter.com), an international center providing comprehensive, specialized eating disorders treatment to female and male adults, adolescents and children, has partnered with the Eating Disorder Center at San Antonio (EDCASA).

16 Apr 2014

Protein expression predicts postop NSCLC recurrence, survival

US-based researchers have identified a panel of 12 proteins that may help predict overall survival and the risk of recurrence in patients treated with surgery for non-small-cell lung cancer.

15 Apr 2014

Daylight Medical releases SKY 6Xi disinfection technology for mobile devices

Daylight Medical, manufacturer and provider of innovative medical products, is pleased to announce its rollout of SKY 6Xi, disinfection technology for mobile devices. SKY 6Xi uses high intensity (254 nanometer wavelength) ultraviolet light in the "C" spectrum (UVC) at close proximity to thoroughly disinfect a mobile device. The unique power of SKY reduces the risk that Hospital-acquired infections (HAIs) are transmitted to patients while improving safety for healthcare workers.

15 Apr 2014

New blood test accurately detects presence of breast cancer and monitors response to treatment

Johns Hopkins Kimmel Cancer Center investigators report they have designed a blood test that accurately detects the presence of advanced breast cancer and also holds promise for precisely monitoring response to cancer treatment.

15 Apr 2014

FDA approves Lannett's ANDA for Diazepam Oral Solution

Lannett Company, Inc. today announced that it has received approval from the U.S. Food and Drug Administration of its Abbreviated New Drug Application (ANDA) for Diazepam Oral Solution (Concentrate), 5 mg/mL, a Schedule C-IV controlled drug.

15 Apr 2014